Literature DB >> 3736751

Mexiletine: biphasic action on convulsive seizures in rodents.

G J Alexander, L M Kopeloff, R B Alexander, N Chatterjie.   

Abstract

Mexiletine, an antiarrhythmic drug, exerted a protective effect in mice against convulsive seizures induced by electroshock or the chemical convulsant, pentylenetetrazol, and against seizures induced in inbred audiosusceptible mice by a sound signal. Administered in large doses, mexiletine produced a hyperkinetic myoclonic syndrome of 30-60 min duration. The hyperkinesia could be controlled by dimethylaminoethanol, phenobarbital and by an experimental anticonvulsive agent, eboracin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736751

Source DB:  PubMed          Journal:  Neurobehav Toxicol Teratol        ISSN: 0275-1380


  4 in total

1.  In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels.

Authors:  M Wienrich; M Brenner; W Löscher; R Palluk; M Pieper; H Potschka; T Weiser
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Barbara Piskorska
Journal:  Neurochem Res       Date:  2016-01-06       Impact factor: 3.996

3.  Interactions of Mexiletine with Novel Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis.

Authors:  Dorota Wróblewska; Monika Rudkowska; Monika Banach; Kinga K Borowicz-Reutt
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

4.  Design, synthesis and anticonvulsant-analgesic activity of new N-[(phenoxy)alkyl]- and N-[(phenoxy)ethoxyethyl]aminoalkanols.

Authors:  Anna Rapacz; Anna M Waszkielewicz; Katarzyna Pańczyk; Karolina Pytka; Paulina Koczurkiewicz; Kamil Piska; Elżbieta Pękala; Bogusława Budziszewska; Beata Starek-Świechowicz; Henryk Marona
Journal:  Medchemcomm       Date:  2016-11-11       Impact factor: 3.597

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.